Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway

Pharmaceutical Biology

Volumn 52, Issue 4, 2014, Pages 466-470

  Huang, Wen Jun ^b   Bi, Ling Yun ^c   Li, Zhen Zhao ^a   Zhang, Xing ^b   Ye, Yu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

^c XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Bax; formononetin; insulin like growth factor 1 receptor; phytoestrogen; prostate cancer cell

Indexed keywords

FORMONONETIN; MESSENGER RNA; PROTEIN BAX; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MITOCHONDRIAL APOPTOSIS; MTT ASSAY; PC 3 CELL LINE; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84908620480     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.842600     Document Type: Article

References (30)

1. Bemis DL, Capodice JL, Desai M, et al. (2004). A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin Cancer Res 10:5282-92.
2. Burfeind P, Chernicky CL, Rininsland F, et al. (1996). Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 93:7263-8.
3. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279:563-6.
4. Chen J, Liu L, Hou R, et al. (2011a). Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett 308:144-51.
5. Chen J, Sun L. (2012). Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptorpositive human breast cancer cells. Horm Metab Res 44:943-8.
6. Chen J, Zeng J, Xin M, et al. (2011b). Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 43:681-6.
7. Coleman IM, Kiefer JA, Brown LG, et al. (2006). Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes. Neoplasia 8: 862-78.
8. DiGiovanni J, Kiguchi K, Frijhoff A, et al. (2000). Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97:3455-60.
9. Gallagher EJ, LeRoith D. (2010). The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21:610-18.
10. Grzmil M, Hemmerlein B, Thelen P, et al. (2004). Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. J Pathol 202:50-9.
11. Harris WP, Mostaghel EA, Nelson PS, Montgomery B. (2009). Androgen deprivation therapy: Progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol 6:76-85.
12. Hoimes CJ, Kelly WK. (2010). Redefining hormone resistance in prostate cancer. Ther Adv Med Oncol 2:107-23.
13. Jarred RA, Keikha M, Dowling C, et al. (2002). Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 11:1689-96.
14. Kašparová M, Siatka T, Klimešová V, Dušek J. (2012). New synthetic pyridine derivate as potential elicitor in production of isoflavonoids and flavonoids in Trifolium pratense L. suspension culture. Scientific World J 2012:746412.
15. Key TJ, Appleby PN, Reeves GK, Roddam AW. (2010). Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-42.
16. Kuiper GG, Lemmen JG, Carlsson B, et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-63.
17. Lau KM, LaSpina M, Long J, Ho SM. (2000). Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60:3175-82.
18. Lee MM, Gomez SL, Chang JS, et al. (2003). Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12:665-8.
19. Li Y, Wang Z, Kong D, et al. (2008). Regulation of Akt/FOXO3a/GSK- 3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283:27707-16.
20. Peeters PH, Lukanova A, Allen N, et al. (2007). Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14:81-90.
21. Peng P, Gong YM, Bao PP, et al. (2012). Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 33:1056-9.
22. Pollak MN, Schernhammer ES, Hankinson SE. (2004). Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-18.
23. Samani AA, Yakar S, LeRoith D, Brodt P. (2007). The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 28:20-47.
24. Shimizu H, Ross RK, Bernstein L, et al. (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963-6.
25. Siegel R, Naishadham D, Jemal A. (2012). Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
26. Venkatesan B, Prabhu SD, Venkatachalam K, et al. (2010). WNT1- inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal 22:809-20.
27. Xu T, Wang NS, Fu LL, et al. (2012). Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. Mol Biol Rep 39:7743-53.
28. Yan L, Spitznagel EL. (2009). Soy consumption and prostate cancer risk in men: A revisit of a meta-analysis. Am J Clin Nutr 89:1155-63.
29. Ye Y, Hou R, Chen J, et al. (2012). Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation. Horm Metab Res 44:263-7.
30. Zong WX, Li C, Hatzivassiliou G, et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162:59-69.